Swiss National Bank’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
197,400
+13,400
| +7% | +$124K | ﹤0.01% | 1850 |
|
|
2025
Q1 | $1.35M | Hold |
184,000
| – | – | ﹤0.01% | 1988 |
|
|
2024
Q4 | $1.57M | Sell |
184,000
-13,900
| -7% | -$119K | ﹤0.01% | 1986 |
|
|
2024
Q3 | $1.72M | Hold |
197,900
| – | – | ﹤0.01% | 1950 |
|
|
2024
Q2 | $1.35M | Buy |
+197,900
| New | +$1.35M | ﹤0.01% | 2015 |
|
|
2022
Q2 | – | Sell |
-172,100
| Closed | -$852K | – | 2773 |
|
|
2022
Q1 | $852K | Buy |
172,100
+12,100
| +8% | +$59.9K | ﹤0.01% | 2470 |
|
|
2021
Q4 | $1.12M | Buy |
160,000
+16,700
| +12% | +$116K | ﹤0.01% | 2421 |
|
|
2021
Q3 | $1.43M | Buy |
143,300
+2,200
| +2% | +$22K | ﹤0.01% | 2244 |
|
|
2021
Q2 | $2M | Buy |
141,100
+2,500
| +2% | +$35.5K | ﹤0.01% | 2094 |
|
|
2021
Q1 | $2.27M | Buy |
138,600
+1,500
| +1% | +$24.6K | ﹤0.01% | 1922 |
|
|
2020
Q4 | $2.84M | Buy |
+137,100
| New | +$2.84M | ﹤0.01% | 1708 |
|
|
2016
Q4 | – | Sell |
-19,000
| Closed | -$131K | – | 2569 |
|
|
2016
Q3 | $131K | Hold |
19,000
| – | – | ﹤0.01% | 2529 |
|
|
2016
Q2 | $94K | Buy |
19,000
+2,200
| +13% | +$10.9K | ﹤0.01% | 2578 |
|
|
2016
Q1 | $156K | Buy |
16,800
+3,800
| +29% | +$35.3K | ﹤0.01% | 2578 |
|
|
2015
Q4 | $122K | Hold |
13,000
| – | – | ﹤0.01% | 2629 |
|
|
2015
Q3 | $183K | Buy |
13,000
+2,200
| +20% | +$31K | ﹤0.01% | 2506 |
|
|
2015
Q2 | $227K | Buy |
+10,800
| New | +$227K | ﹤0.01% | 2524 |
|